RecruitingNot ApplicableNCT05382663

The Jordan Study for End-Stage Renal Disease Subjects

Non-Invasive Monitoring of End-Stage Renal Disease Subjects Using Alio Medical Remote Monitoring System (RMS)


Sponsor

Alio, Inc.

Enrollment

75 participants

Start Date

Mar 21, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

To compare the Alio device to blood draws.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a wearable monitoring patch (called SmartPatch) that tracks dialysis access health in people with end-stage kidney disease who receive dialysis through an arteriovenous fistula or graft (a surgically created blood vessel connection in the arm). **You may be eligible if...** - You are 18 or older - You are receiving ongoing dialysis for end-stage kidney disease through an arteriovenous fistula or graft located in your arm - You have been on dialysis for at least 6 months - You are willing to wear the SmartPatch as instructed **You may NOT be eligible if...** - The skin near the patch placement site is swollen, infected, or inflamed - You are pregnant - Your dialysis access is not located in your arm - You are participating in another clinical trial that could affect this study's data Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAlio Device

Non-invasive device worn over vasculature.


Locations(1)

Jordan Center for Pharmaceutical Research

Amman, Jordan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05382663


Related Trials